Skip to main content
TipRanks
Go Ultimate75% OFF

LENZ Therapeutics (LENZ) Ratios

427 Followers

LENZ Therapeutics Ratios

LENZ's free cash flow for Q3 2026 was $-22.31M. For the 2026 fiscal year, LENZ's free cash flow was increased by $0.00 and operating cash flow was $-22.31M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio14.2320.363.634.9114.62
Quick Ratio14.2320.363.634.9114.62
Cash Ratio1.191.941.904.6814.61
Solvency Ratio-3.80-4.43-0.43-0.15-2.15
Operating Cash Flow Ratio-3.26-5.71-3.26-9.26-42.18
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 279.88M$ 200.70M$ -95.84M$ -24.48M$ -14.23M
Leverage Ratios
Debt-to-Assets Ratio0.000.010.000.010.00
Debt-to-Equity Ratio0.000.01-0.00-0.010.00
Debt-to-Capital Ratio0.000.01-0.00-0.010.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.081.05-0.76-1.94-1.29
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.030.060.040.030.00
Net Debt to EBITDA0.300.380.484.220.26
Profitability Margins
Gross Profit Margin96.31%0.00%0.00%100.00%0.00%
EBIT Margin-427.62%0.00%0.00%-69.89%0.00%
EBITDA Margin-426.12%0.00%0.00%-69.83%0.00%
Operating Profit Margin-477.46%0.00%0.00%-69.89%0.00%
Pretax Profit Margin-427.62%0.00%0.00%-69.76%0.00%
Net Profit Margin-430.25%0.00%0.00%-72.07%0.00%
Continuous Operations Profit Margin-430.25%0.00%0.00%-72.07%0.00%
Net Income Per EBT100.62%100.00%99.74%103.32%100.00%
EBT Per EBIT89.56%84.91%96.85%99.82%117.07%
Return on Assets (ROA)-26.85%-23.12%-99.42%-23.03%-385.93%
Return on Equity (ROE)-28.88%-24.39%75.47%44.73%497.82%
Return on Capital Employed (ROCE)-32.01%-28.60%-139.66%-27.99%-353.84%
Return on Invested Capital (ROIC)-31.96%-28.53%-138.93%-27.91%-353.84%
Return on Tangible Assets-26.85%-23.12%-99.42%-23.03%-385.93%
Earnings Yield-17.81%-8.10%-69.28%-8.78%-14.51%
Efficiency Ratios
Receivables Turnover7.860.000.000.000.00
Payables Turnover0.170.010.000.001.60
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover9.930.000.0053.760.00
Asset Turnover0.060.000.000.320.00
Working Capital Turnover Ratio0.080.000.000.550.00
Cash Conversion Cycle-2110.94-26789.740.000.00-228.75
Days of Sales Outstanding46.450.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding2157.3826789.740.000.00228.75
Operating Cycle46.450.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-2.40-2.79-7.41-11.22-6.38
Free Cash Flow Per Share-2.43-2.81-7.42-12.06-7.07
Dividend Paid and CapEx Coverage Ratio-83.64-0.19-2012.67-13.34-9.21
Capital Expenditure Coverage Ratio-83.64-126.90-2012.67-13.34-9.21
Operating Cash Flow Coverage Ratio-84.87-43.01-183.53-351.920.00
Operating Cash Flow to Sales Ratio-3.620.000.00-5.870.00
Free Cash Flow Yield-15.18%-9.74%-59.81%-76.79%-12.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-5.61-12.34-1.44-11.39-6.89
Price-to-Sales (P/S) Ratio24.150.000.008.210.00
Price-to-Book (P/B) Ratio1.623.01-1.09-5.10-34.30
Price-to-Free Cash Flow (P/FCF) Ratio-6.59-10.26-1.67-1.30-8.32
Price-to-Operating Cash Flow Ratio-6.66-10.34-1.67-1.40-9.22
Price-to-Earnings Growth (PEG) Ratio-0.260.15-0.08-0.22-1.90
Enterprise Value Multiple-5.37-11.98-0.91-7.54-6.70
Enterprise Value436.65M595.61M66.19M78.96M469.23M
EV to EBITDA-5.37-11.98-0.91-7.54-6.70
EV to Sales22.880.000.005.260.00
EV to Free Cash Flow-6.24-9.95-1.10-0.83-8.01
EV to Operating Cash Flow-6.31-10.03-1.10-0.90-8.88
Tangible Book Value Per Share9.879.59-11.38-3.08-1.72
Shareholders’ Equity Per Share9.879.59-11.38-3.08-1.72
Tax and Other Ratios
Effective Tax Rate-0.01-0.000.00-0.030.00
Revenue Per Share0.660.000.001.910.00
Net Income Per Share-2.85-2.34-8.59-1.38-8.54
Tax Burden1.011.001.001.031.00
Interest Burden1.001.000.971.001.00
Research & Development to Revenue0.980.000.001.410.00
SG&A to Revenue4.760.000.000.000.00
Stock-Based Compensation to Revenue0.660.000.000.000.00
Income Quality0.841.190.860.870.75

Currency in USD